A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

This trial is open and accepting eligible patients.

Trial Overview

The purpose of this research study is to compare the survival rates of patients with better risk disease undergoing hematopoietic stem cell transplant (HSCT) to the survival rates reported in the medical literature of similar patients undergoing reduced intensity HSCT from matched related donors.

What is the phase of this trial?

Phase 2 what does this mean

What type of trial is this?

This is an interventional trial. This type of trial actively treats your myeloma.

What treatments are used in this trial?
Trial Locations

There are 1 trial site around the United States.
Find the closest trial site.

How many patients will participate in this trial?

Approximately 50 patients will be enrolled in this study.

Who is sponsoring this trial?

Thomas Jefferson University

SparkCures Trial Identifiers

MM-0133 , NCT01384513 what is this

1 US location

Am I Eligible For This Trial?

All clinical trials provide reasons that patients may or may not be able to join called 'eligibility criteria'. The following is a high-level eligibility criteria provided by the sponsor of this trial. Additional eligibility criteria may apply.

Trial Contact Information

Trial locations are sorted by state. Enter your zip code to sort by closest distance.


Thomas Jefferson University

(Sidney Kimmel Medical College)

130 S 9th Street, Philadelphia, PA 19107

This site is open and accepting eligible patients.

There is 1 active US location.